• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Lotus Submits Cannabis License Evidence Package to Health Canada

    Anwesha Sengupta
    Feb. 11, 2019 06:21AM PST
    Cannabis Investing News
    CSE:J

    Lotus Ventures Inc (CSE:J) (Frankfurt: LV9) announced today that it has reached a major milestone by submitting its Cannabis License Evidence Package to Health Canada.

    Lotus Ventures Inc (CSE:J) (Frankfurt: LV9) announced today that it has reached a major milestone by submitting its Cannabis License Evidence Package to Health Canada. The Company has constructed its state-of-the-art indoor production facility, located in BC’s Okanagan valley, to comply with the regulations under the Cannabis Act, and now awaits a license from Health Canada to cultivate. Once licensed, Lotus will commence cultivation from its climate-controlled facility, utilizing the talents of their lead growers. The team has deep roots in the BC cannabis community, which will give Lotus the ability to consistently produce some of the best quality cannabis available.

    Lotus would like to thank everyone who has contributed to this project so far, including builders, suppliers and local officials. “We look forward to the next catalysts throughout the year as we obtain our licenses, ramp-up production, build new facilities, and launch our retail brand” said Dale McClanaghan, CEO.

    The Company wishes to thank its shareholders for their patience over these many years, and we look forward to sharing our successes with you, as we take our place in this disruptive new industry.

    ON BEHALF OF THE BOARD

    Lotus Ventures Inc.
    “Dale McClanaghan”
    Dale McClanaghan, President and CEO

    About Lotus Ventures, Inc.
    Lotus is a late stage licensed producer applicant under the Cannabis Act, in active review with Health Canada. The unique business model combines an upstream royalty financing model with Auxly and a downstream licensing model with farmer/grower partners using Lotus technology and intellectual property. The first facility in Spallumcheen, B.C. is a purpose built, “state of the art” indoor facility with proprietary processes.

    For further information: Dale McClanaghan: dalemcclanaghan@gmail.com, (604) 644-9844, or Daniel McRobert, Investor Relations, danielmcrobertt@gmail.com (604) 842-4625

    Click here to connect with Lotus Ventures Inc (CSE:J) for an Investor Presentation. 

    Source: www.newswire.ca

    cse:jcannabis investinglotus ventures incb.c.
    The Conversation (0)

    Go Deeper

    AI Powered
    Nextleaf Solutions

    Nextleaf Solutions

    Cannabis Weekly Round-Up: Ex-CannTrust Execs Get Fraud Charges

    Cannabis Weekly Round-Up: Ex-CannTrust Execs Get Fraud Charges

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×